| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/15/2005 | CN1626068A Combination of medication in use for improving dissolution of curcumin and bioavailability as well as preparation method |
| 06/15/2005 | CN1625963A Capsule of natural protein containing selenium and root of pilose asiabell |
| 06/15/2005 | CN1206363C Process for obtaining of HMG-CO a reductase inhibitors of high purify |
| 06/15/2005 | CN1206242C Anti-angiogenesis and anti-cancer function of angiogenin combined with nucleotide |
| 06/15/2005 | CN1206228C N-heterocyclic derivatives as NOS inhibitors |
| 06/15/2005 | CN1206224C Substituted benzylthiazolidine-2,4-dione derivatives |
| 06/15/2005 | CN1206212C Tri-substd. phenyl derivs. and analogues |
| 06/15/2005 | CN1206133C Infusion packet and its use |
| 06/15/2005 | CN1205994C Pulmonary delivery of active agents |
| 06/15/2005 | CN1205990C Medicine for reating diabetes mellitus |
| 06/15/2005 | CN1205974C Medicinal compn. for treating diabetes |
| 06/15/2005 | CN1205973C Chinese medicinal granular for reating diabetes |
| 06/15/2005 | CN1205935C Highly selective norepinephrine reuptake inhibitors and methods of using same |
| 06/15/2005 | CN1205934C Composition for treating hyperlipemia |
| 06/15/2005 | CN1205933C Slow-releasing acipimox capsule |
| 06/15/2005 | CN1205931C Pharmaeutical agent comprising benzamide derivative as active ingredient |
| 06/14/2005 | US6906210 Method for producing lipoic acid and dihydrolipoic acid |
| 06/14/2005 | US6906204 Processing method of lactionization in the preparation of statins |
| 06/14/2005 | US6906175 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. |
| 06/14/2005 | US6906174 Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906089 Kidney disease; cardiovascular disorders; antiscarring agents; wound healing agents |
| 06/14/2005 | US6906082 Cholesteryl ester transfer protein inhibitor; anticholesterol agents, cardiovascular disorders; synergistic mixture |
| 06/14/2005 | US6906080 Antiinflammatory agents, analgesics, drug abuse, alcoholism |
| 06/14/2005 | US6906075 Contacting a sample with substituted benzoimidazole analogues under conditions that permit binding of such analogue to melanin concentrating hormone (MCH) receptor to determine the presence and absence of MCH |
| 06/14/2005 | US6906058 Prevent bile acid transportation; anticholesterol agents |
| 06/14/2005 | US6906053 Antiarthritic agents; antiulcer agents; osteoporosis; antiinflammatory agents; antitumor and anticancer agents |
| 06/14/2005 | US6906051 Viricides, fungicides, microbiocides, osteoporosis |
| 06/14/2005 | US6906041 Treatment of immune diseases |
| 06/14/2005 | US6906028 Stable insulin formulations |
| 06/14/2005 | US6906027 Composition for nasal administration of insulin |
| 06/14/2005 | US6905855 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 06/14/2005 | US6905688 Comprises therapeutic fusion proteins for diagnosis and treatment of cancers, neovascularization and autoimmune diseases |
| 06/14/2005 | US6905687 Fusion proteins; immunogens; solid phase synthesis; kits |
| 06/14/2005 | US6905685 Antiproliferative agents; monoclonal antibodies; blocking immunology response; autoimmune disease, antidiabetic agents, antiarthritic agents, antitumor, anticancer agents |
| 06/14/2005 | CA2258893C Anticonvulsant sulfamate derivatives useful in treating obesity |
| 06/14/2005 | CA2155952C Novel process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis |
| 06/14/2005 | CA2112017C Use of benzothiophenes for lowering serum cholesterol |
| 06/14/2005 | CA2100423C Parathyroid hormone analogs having parathyroid hormone-like activity |
| 06/09/2005 | WO2005051949A1 Novel condensed imidazole derivative |
| 06/09/2005 | WO2005051894A1 Novel salicylic anilides |
| 06/09/2005 | WO2005051110A1 Corrective clothes with crotch |
| 06/09/2005 | WO2005009276A3 Microbial cellulose wound dressing |
| 06/09/2005 | WO2004043956A8 Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same |
| 06/09/2005 | WO2004012671A3 Substituted furo [2,3-b] pyridine derivatives |
| 06/09/2005 | US20050124979 Miniaturized device; substrate with reservoirs; aperture; barrier covering; sustained release |
| 06/09/2005 | US20050124795 DNA encoding a human subunit 5-HT3-C of the 5-HT3 serotonin receptor |
| 06/09/2005 | US20050124793 Novel proteins and dnas thereof |
| 06/09/2005 | US20050124787 Process for preparing water soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 06/09/2005 | US20050124696 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124693 Biguanide derivative and therapeutic agent for diabetes containing the same |
| 06/09/2005 | US20050124689 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 06/09/2005 | US20050124682 Such as N-{2-[5-(methylthio)-1H-indol-3-yl]ethyl}acetamide for treatment of disorders of the melatoninergic system; hormone replacement therapy |
| 06/09/2005 | US20050124665 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance |
| 06/09/2005 | US20050124656 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 06/09/2005 | US20050124652 Guanidino compounds |
| 06/09/2005 | US20050124649 Deazapurines and uses thereof |
| 06/09/2005 | US20050124647 For example, 4-hydroxy-1,1-di-(5',6'-methylendioxy-indol-2-yl)-butane; antitumor agents, particularly for treating mammary carcinoma and colon carcinoma |
| 06/09/2005 | US20050124641 Process for preparing chiral diol sulfones and dihydroxy acid HMG CoA reductase inhibitors |
| 06/09/2005 | US20050124640 Pyrimidine derivatives useful as inhibitors of PKC-theta |
| 06/09/2005 | US20050124632 Use of aminobenzenesulfonic acid derivative or a salt, hydrate, or solvate thereof; treatment of heart failure or arrhythmia in diabetic ischemic heart disease |
| 06/09/2005 | US20050124631 For example, 2-amino-7-chloro-6-hydroxy-4-methylbenzothiazole; compounds that prevent the formation of polyglutamine containing protein aggregates; treatment of spinal and bulbar muscular atrophy, dentatorubal pallidoluysian atrophy, spinocerebellar ataxia, Alzheimers disease |
| 06/09/2005 | US20050124628 Quinoline and aza indole compounds having pharmacological activity, for example, 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; use in the treatment of CNS and other disorders |
| 06/09/2005 | US20050124626 Novel compounds |
| 06/09/2005 | US20050124621 Novel inhibitors of kinases |
| 06/09/2005 | US20050124615 3-heteroarly-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b] indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 06/09/2005 | US20050124597 Novel guanidinyl derivatives |
| 06/09/2005 | US20050124586 Alpha-substituted arylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124581 Alpha-substituted heteroarylalkyl phosphonate derivatives |
| 06/09/2005 | US20050124574 Purine derivatives |
| 06/09/2005 | US20050124558 Controlling particle size; bioavailability |
| 06/09/2005 | US20050124557 Use of benzothiazepines having activity as inhibitors of ileal bile acid transport for reducing cholesterololemia |
| 06/09/2005 | US20050124555 Azulene derivatives and salts thereof |
| 06/09/2005 | US20050124552 Use of glutathione synthesis stimulating compounds in reducing insulin resistance |
| 06/09/2005 | US20050124539 Ligand which binds to polypeptides; controlling eating disorders; screening process |
| 06/09/2005 | US20050124537 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/09/2005 | US20050124004 Histamine receptor h3 polynucleotides |
| 06/09/2005 | US20050123912 Nucleoprotein for use as tool in treatment, diagnosis and prevention of infection, cell proliferative, neurological, developmental, autoimmune and inflammatory disorders |
| 06/09/2005 | US20050123897 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area; drug delivery kits, patches |
| 06/09/2005 | US20050123662 Soybean saponin-containing material and process for producing the same |
| 06/09/2005 | US20050123633 Obtained by fermenting soybean germ, which is used as raw material, with koji mold, thus breaking down proteins, then hydrolyzing, extracting and concentrating using solvent to produce an isoflavone aglycone concentrate |
| 06/09/2005 | US20050123558 Modifeid polypeptide |
| 06/09/2005 | US20050123531 Administering to the individual therapeutically effective amount of human acid alpha-glucosidase at regular interval for therapy of glycogen storage disease type II |
| 06/09/2005 | US20050123512 Binding agents, vectors, host cells; gene therapy; nucleotide sequence with DNA insert encoding polypeptide; genetic engineering; medical diagnosis |
| 06/09/2005 | DE68918191C5 Verfahren zur Lactonisierung von Mevinsäuren und deren Analogen. A method for lactonization of Mevinsäuren and their analogs. |
| 06/09/2005 | DE102004054133A1 Silymarin-based food supplement for improving diet and reducing the risk of diseases of civilization, e.g. diabetes, contains a standardized flavonolignan fraction from Marian thistle and a dried Yacon root preparation |
| 06/09/2005 | CA2547430A1 Receptor function regulating agent |
| 06/09/2005 | CA2547146A1 Diphenylamine derivatives |
| 06/09/2005 | CA2545823A1 4-oxo-4,5-dihydro-furan-2-carboxylic and acid derivatives and methods of treatment of metabolic-related disorders thereof |
| 06/09/2005 | CA2545655A1 Combination drug therapy to treat obesity |
| 06/09/2005 | CA2545473A1 Macromolecular drug complexes having improved stability and therapeutic use of the same |
| 06/09/2005 | CA2545023A1 Novel salicylic anilides |
| 06/09/2005 | CA2544522A1 Vitamin d receptor modulators |
| 06/08/2005 | EP1538217A1 Method of screening insulin content enhancer |
| 06/08/2005 | EP1537880A1 Sustained release preparation |
| 06/08/2005 | EP1537870A2 Methods and compositions for treating cancer |
| 06/08/2005 | EP1537865A1 Use of sulfur containing compounds and proteolytic enzymes for the prevention and therapy of the UDP-Glucuronosyltransferase 1 deficient Type II Diabetes mellitus |
| 06/08/2005 | EP1537138A2 Receptors and membrane-associated proteins |
| 06/08/2005 | EP1537124A1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 06/08/2005 | EP1537112A1 Condensed pyridines and pyrimidines with tie2 (tek) activity |